AVIGBAGENE PARVEC EXPRESSED .BETA.-GLUCOCEREBROSIDASE PROTEIN (VARIANT 351-CYSTEINE, 380-CYSTEINE)
UNII 37B8F3G9CC

Substance Identification & Data

This profile provides standardized clinical and technical data for Avigbagene Parvec Expressed .beta.-glucocerebrosidase Protein (variant 351-cysteine, 380-cysteine), uniquely identified by the FDA Unique Ingredient Identifier (UNII) 37B8F3G9CC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
37B8F3G9CC
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
AVIGBAGENE PARVEC EXPRESSED .BETA.-GLUCOCEREBROSIDASE PROTEIN (VARIANT 351-CYSTEINE, 380-CYSTEINE)
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Avigbagene Parvec Expressed .beta.-glucocerebrosidase Protein (variant 351-cysteine, 380-cysteine). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

AVIGBAGENE PARVEC EXPRESSED .BETA.-GLUCOCEREBROSIDASE PROTEIN (VARIANT 351-CYSTEINE, 380-CYSTEINE)

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record